Drug recall D-0464-2021
Product
Nadolol Tablets, USP 40 mg 100 Tablets Rx Only NDC 69097-868-07 Manufactured for: Cipla USA Inc. 9100 S. Dadeland Blvd., Suite 1599 Miami, FL 33156
Reason for recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots and codes
NB100156
Recall details
- Recalling firm
- Cardinal Health Inc., Dublin, OH
- Quantity
- 40 bottles
- Distribution
- FL, GA, SC
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 15, 2021
- Terminated
- June 17, 2024
Related products
- Nadolol – drug information
- NDC 69097-869 Nadolol · Nadolol 80 mg/1 · Cipla USA Inc.
- NDC 69097-868 Nadolol · Nadolol 40 mg/1 · Cipla USA Inc.
- NDC 69097-867 Nadolol · Nadolol 20 mg/1 · Cipla USA Inc.